Tibor Nadasdy

Tibor Nadasdy

Auto-generated profile, based on publicly available information

Tibor Nadasdy

Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2019 in Nature Reviews Nephrology
Verified
Journal Article
Closed access
ASAnjali A. Satoskar
Anjali A. Satoskar
SPSamir V. Parikh
Samir V. Parikh
TNTibor Nadasdy
Tibor Nadasdy

1 January 2005 in Ultrastructural Pathology
Verified
Journal Article
Closed access
CMCynthia M. Magro
Cynthia M. Magro
ECEdward Calomeni
Edward Calomeni
TNTibor Nadasdy
Tibor Nadasdy
BSBlake D. Shusterman
Blake D. Shusterman
APAmy L. Pope-Harman
Amy L. Pope-Harman
PRPatrick Ross
Patrick Ross
Humoral immunity contributes significantly to lung graft dysfunction. Recognizing a role of ultrastructural studies in the evaluation and diagnosis of chronic humoral allograft rejection in the kidney, the authors sought to explore its utility as a diagnostic adjunct in lung allograft biopsies. Ultrastructural studies were conducted on 44 biopsies from 26 lung transplant recipients. Endothelial cell activation and necrosis were seen in the setting of acute humoral allograft rejection. Septal chronic vasculopathic changes of thickening and lamellation of the basement membrane zone (BMZ) and BMZ collagen deposition were correlated with greater numbers of humoral allograft rejection episodes and with the development of chronic graft dysfunction/bronchiolitis obliterans syndrome. There was a positive correlation between the extent of septal fibrosis and certain chronic vasculopathic changes, namely collagen deposition in the BMZ and BMZ wrinkling. Patients with chronic graft dysfunction and multiple rejection episodes manifested low diffusion capacities (less than 50% predicted). The results indicate that ultrastructural analysis is useful in identification of septal fibrosis and chronic vasculopathy of the septal microvasculature, correlating with chronic graft dysfunction, encompassing not only fibrotic sequelae of the bronchial wall but also irreversible terminal lung parenchymal changes, the latter associated with repeated episodes of humoral rejection.

5 April 2018 in Case Reports in Nephrology
Verified
Journal Article
Open access
PDF file
RKRishi Kora
Rishi Kora
SBSergey V. Brodsky
Sergey V. Brodsky
TNTibor Nadasdy
Tibor Nadasdy
DADean Agra
Dean Agra
ASAnjali A. Satoskar
Anjali A. Satoskar
Rifampicin is a key component of multidrug regimens not only for tuberculosis, but also nontuberculous mycobacterial infections (NTM) which are on the rise worldwide. Knowledge of the toxicity profile is important. Hepatotoxicity is a well-known side effect of Rifampicin necessitating regular liver function monitoring during therapy. Acute kidney injury (AKI) is a relatively rare complication, usually resulting from allergic interstitial nephritis (AIN). Rifampicin-induced intravascular hemolysis resulting in hemoglobinuria and AKI is even more uncommon, especially in Western countries with low prevalence of mycobacterial infections. Rifampicin-induced antibodies are implicated and this complication preferentially occurs during intermittent drug treatment protocols or when Rifampicin is restarted after a long drug-free interval. Awareness of this drug complication and its unique timing is important especially among emergency room physicians where patients with AKI may first present. It is equally important for nephrologists and pathologists. We describe one such case with detailed clinical course of the patient and interesting biopsy findings of ATN with intratubular hemoglobin casts.